We aim to create diagnostic tests for TB that are accessible, accurate, and affordable.
Our target for 2030 is to test over a billion people.
Our team includes researchers at the forefront of TB diagnostics, as well as experienced clinicians and operations specialists.
Over the last twelve years our team have lead cutting edge research into the next generation of TB diagnostics. We hold multiple patents and have been cited and awarded globally.